Market Pulse: Global equities edged sideways after top Indian IT services firms flagged another subdued quarter amid waning US client budgets. Meanwhile, crypto markets oscillated wildly as XRP saw a purge of long positions and Bitcoin triggered a resurgence of FOMO. Media stocks and regulatory updates rounded out the volatility brew.
Key Movers: TCS and Infosys led the tech underperformers once more, jittery on private-sector cutbacks. XRP liquidation waves on Binance decimated weak hands while Bitcoin’s metric reversal put bulls back in play. Warner Bros. Discovery and Paramount Skydance remained at odds in a takeover standoff.
Macro & Politics: Fed minutes loom large after Wall Street priced in a hawkish tilt, but whispers of slower growth may sway the curve yet. No major geopolitical events hit overnight, but activist investors could tip the scales in media mergers today.
What’s Next: Eyes on tomorrow’s Fed minutes and next week’s jobs report as traders search for a clear directional signal.
📈 Breaking Financial News
Goldman: Silver faces continued ‘extreme price swings' as the metal may stay stuck in the wrong places
Silver prices more than doubled in 2025 in its best year since 1979 thanks to Fed rate cuts, asset diversification, and a historic short squeeze.
Cal-Maine Shows Resilience In Tough Egg Market
Cal-Maine Foods, Inc. (NASDAQ:CALM) stock rose Wednesday after the egg producer delivered a second-quarter earnings beat, easing investor concerns over falling egg prices even as revenue and profitability slid sharply year over year.
Warner Bros. Discovery rejects latest takeover bid from Paramount Skydance: ‘They’re not listening to us’
Warner Bros. Discovery rejected the latest takeover bid from Paramount Skydance — the latter’s seventh straight overture — citing uncertainties around the debt financing tied to the offer as WBD continued to tout its merger deal with Netflix.
BioXcel Therapeutics planning to submit sNDA seeking FDA approval for IGALMI
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Indian top IT firms set for another tepid quarter on weak US demand, client spending
As Indian IT companies gear up for what is expected to be a slow quarter, weak demand from the U.S. continues to dampen tech spending. Market analysts project only slight increases in revenue and profits for leading firms. Nevertheless, the growing trend of A…
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.
🔍 Market Analysis & Insights
Indian top IT firms set for another tepid quarter on weak US demand, client spending
Jan 8 : India's information technology firms are expected to report another muted quarter, as tepid demand in the U.S. and holiday-period client shutdowns continue to weigh on tech spending, nine brokerages said ahead of earnings. Brokerages expect the top si…
Indian top IT firms set for another tepid quarter on weak US demand, client spending
India's information technology firms are expected to report another muted quarter, as tepid demand in the U.S. and holiday-period client shutdowns continue…
Best Oral Peptides for Weight Loss: Injectable vs Sublingual vs Daily Pill – Direct Meds Consumer Analysis
January 2026 consumer analysis compares oral Wegovy, compounded sublingual semaglutide, and tirzepatide drops across pricing and access formats….
XRP Sees Back-to-Back Liquidation Waves: Binance Absorbs Majority Of Liquidations
XRP is trading above the $2.20 level after several days of relief-driven price action, offering bulls a temporary pause following months of sustained selling pressure. The rebound has eased short-term stress, but conviction remains fragile. Analysts are incre…
NeuroPrime Tonic Examined: Consumer Report on the Liquid Memory Support Formula's Nine Botanical Ingredients, Published Research Context, and Buyer Considerations Entering 2026
Independent analysis addresses NeuroPrime Tonic legitimacy, ingredient research, pricing transparency, refund policy, and cognitive wellness claims….
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon's $3 Trillion Comeback Could Begin Soon Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America's toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.
💰 Investment Opportunities
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman
Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman….
Plasma: The Future of Sports, World Record Recovery from Achilles Tendon Tear By Teen Squash Champion – TZLA
Historically, plasma and light-based healing has been pushed aside, ridiculed, or buried, while chemical medicine took over. Not because plasma doesn’t work, but because it doesn’t fit the business model. You’ll only hear about plasma in whispers, Telegram gr…
Bitcoin ripped to $94,000 as critical metric quietly turns positive for first time since October
Bitcoin ETFs grabbed $1.2 billion in the first two trading sessions of 2026, coinciding with BTC's climb to $94,000, a 7% gain in just days. The narrative wrote itself: institutional money flooded in, prices followed. Yet, that correlation masks a more comple…
L’Oréal’s new LED face masks address all my issues with this category
I hate when friends and family ask me which LED face mask to buy. That's because LED face masks are another prime example of the wild wellness west. There's compelling science behind using red and infrared light therapy to address skin concerns, particularly …
Luminate Raises $21 Million in Funding to Expand Home Cancer Treatment
ARTIS Ventures, Lachy Groom, and Western Alliance Bank lead funding round in Y Combinator company delivering cancer therapies at home ARTIS Ventures, Lachy Groom, and Western Alliance Bank lead funding round in Y Combinator company delivering cancer therapies…
The Elon Musk “Mystery Metal” That Could Break China's Grip
quietly engineered by Elon Musk… could end that crisis forever. And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now. See more about this secret project here.
Unfiltered Market Commentary
Everyone’s missing that the gloomy outlook in “Indian top IT firms set for another tepid quarter on weak US demand, client spending” (The Times of India) isn't just an India story—it’s a damn warning flare for global tech profit margins. Investors are so hungry for yield that they’re glossing over how a private-sector capex pullback can cascade into every corner of the market. If tech services start shrinking, expect a tougher environment for everything from semiconductor orders to software subscription renewals.
Look at Warner Bros. Discovery’s rejection of Paramount Skydance’s bid (New York Post) and then watch Binance soak up wave after wave of XRP liquidations (newsBTC)—they share a common theme: crowded trades and fragile financing. Whether it’s corporate boards dragging their feet on debt-laden takeovers or crypto leveraged longs blowing up, the underlying risk is liquidity drying up faster than you’d think. If activists or speculators can trigger a chain reaction in either arena, don’t be surprised when volatility spikes with zero warning.
Here’s the play: flank your portfolio with cash cushions—lighten positions in beaten-down IT names and dial back your crypto bets until you see true liquidity resilience. Track activist filings in media mergers and monitor sNDA milestones for biotech underdogs like BioXcel Therapeutics (Thefly.com), because missing these catalysts is a damn oversight. Above all, lock in your risk parameters before tomorrow’s Fed minutes drop—if you wait for clarity, you’ve already given the market the edge.